On previous episodes, we’ve talked about the impact of COVID-19 in the context of public health and incarceration. But, as an organization, how has Drug Policy Alliance been affected? What about our work has changed, and what stays the same? I asked DPA’s Managing Director of Policy, Advocacy and Campaigns, Kassandra Frederique, to break it down for us. (Visit www.drugpolicy.org/covid19 for more information about DPA’s pandemic response.)